Scared if that mole on your face could one day turn out to be skin cancer? Well, then Molemate is sure to allay your fears.
Molemate is a non-invasive, rapid and painless mole-screening device that can enable a medical practitioner to quickly scan one's moles.
Advertisement
It may make it possible to detect the early stages of skin cancer by allowing doctors to screen and evaluate a mole within seconds.
Based on their observations, the doctors may either reassure patients that their moles are harmless or refer them on to a specialist.
According to its manufacturers, the hand-held MoleMate device instantly analyses changes in the main components of skin, thus providing an early diagnosis.
![Skin Disease]( "Skin Disease")
Skin diseases also known as dermatologic disorders are many in number and so are their causes. The common skin diseases or skin disorders are usually related to the epidermal layer of skin.
Currently, Medicalternative, the Edinburgh private clinic, is the only one to provide such scans, charging 100 pounds for screening and evaluation.
"MoleMate is a non-invasive, rapid and painless mole screening device that enables a medical practitioner to quickly scan your moles, showing information up to 2mm under the skin. This can assist them in making an instant decision on the health of the mole," the Scotsman quoted a spokeswoman at Medicalternative as saying.
This device uses light wave technology to break in two millimetres beneath the surface of the skin.
The researchers can then use the differences in the light waves that return to detect potentially harmful changes in colour, blood flow, the skin pigment melanin and collagen that may signal progression to cancer unless treated.
Dr Lindsey Myskow, a part-time NHS GP who runs the screening clinics, said: "We scan the mole for a number of features to see whether it is suspicious or not. The scanner measures these pretty accurately and helps with diagnosis.
The device has been manufactured by Cambridge-based Astron Clinica, which was founded by scientist Symon Cotton in 1998.
Source: ANI
SRM
According to its manufacturers, the hand-held MoleMate device instantly analyses changes in the main components of skin, thus providing an early diagnosis.
Skin Disease
Skin diseases also known as dermatologic disorders are many in number and so are their causes. The common skin diseases or skin disorders are usually related to the epidermal layer of skin.
Advertisement
Currently, Medicalternative, the Edinburgh private clinic, is the only one to provide such scans, charging 100 pounds for screening and evaluation.
"MoleMate is a non-invasive, rapid and painless mole screening device that enables a medical practitioner to quickly scan your moles, showing information up to 2mm under the skin. This can assist them in making an instant decision on the health of the mole," the Scotsman quoted a spokeswoman at Medicalternative as saying.
This device uses light wave technology to break in two millimetres beneath the surface of the skin.
The researchers can then use the differences in the light waves that return to detect potentially harmful changes in colour, blood flow, the skin pigment melanin and collagen that may signal progression to cancer unless treated.
Dr Lindsey Myskow, a part-time NHS GP who runs the screening clinics, said: "We scan the mole for a number of features to see whether it is suspicious or not. The scanner measures these pretty accurately and helps with diagnosis.
The device has been manufactured by Cambridge-based Astron Clinica, which was founded by scientist Symon Cotton in 1998.
Source: ANI
SRM
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
